Insider Transactions last 24 months for Syndax Pharmaceuticals, Inc.  -  NSDQ: SNDX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Goldan Keith A.Chief Financial Officer02/09/2026DSDirectCOM3,410$21.03$71,705.48140,429
Metzger Michael AChief Executive Officer02/09/2026DSDirectCOM17,159$21.03$360,819.45491,690
Goldan Keith A.Chief Financial Officer02/06/2026DSDirectCOM2,082$20.62$42,930.84143,839
Metzger Michael AChief Executive Officer02/06/2026DSDirectCOM7,412$20.62$152,835.44508,849
Legault PierreDirector02/04/2026AADirectCOM24,000$0.00$0.00114,000
Katkin KeithDirector02/04/2026AADirectCOM24,000$0.00$0.00124,000
Rizo AleksandraDirector02/04/2026AADirectCOM24,000$0.00$0.0049,000
Podlesak DennisDirector02/04/2026AADirectCOM48,000$0.00$0.00239,763
Botwood Nicholas A.J.Head of R&D, CMO02/04/2026AADirectCOM36,000$0.00$0.0095,165
Botwood Nicholas A.J.Head of R&D, CMO02/04/2026AADirectCOM24,000$0.00$0.0059,165
Huber Martin H. Jr.Director02/04/2026AADirectCOM24,000$0.00$0.00103,000
Jarrett JenniferDirector02/04/2026AADirectCOM24,000$0.00$0.00114,000
Goldan Keith A.Chief Financial Officer02/04/2026AADirectCOM30,750$0.00$0.00145,921
Goldan Keith A.Chief Financial Officer02/04/2026AADirectCOM21,500$0.00$0.00115,171
Metzger Michael AChief Executive Officer02/04/2026AADirectCOM144,600$0.00$0.00516,261
Metzger Michael AChief Executive Officer02/04/2026AADirectCOM73,000$0.00$0.00371,661
Goldan Keith A.Chief Financial Officer01/30/2026AJDirectCOM1,219$8.48$10,337.1293,671
Goldan Keith A.Chief Financial Officer12/01/2025DGDirectCOM1,224$0.00$0.0092,452
Metzger Michael AChief Executive Officer09/08/2025DSDirectCOM157,307$16.41$2,582,021.37298,661
Metzger Michael AChief Executive Officer09/08/2025AMDirectCOM157,307$10.90$1,714,646.30455,968
Podlesak DennisDirector08/18/2025DSDirectCOM19,200$15.84$304,170.24191,763
Podlesak DennisDirector08/18/2025AMDirectCOM19,200$7.20$138,240.00210,963
Podlesak DennisDirector08/15/2025DSDirectCOM19,200$15.54$298,408.32191,763
Podlesak DennisDirector08/15/2025AMDirectCOM19,200$7.20$138,240.00210,963
Podlesak DennisDirector08/14/2025DSDirectCOM19,200$14.19$272,520.96191,763
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel